Thomas Tueting

598 citations
15 papers · 309 · h-index 7

Impact in

Papers in

    • Immunotherapy and Immune Responses 7
    • T-cell and B-cell Immunology 2
    • Immune Cell Function and Interaction 2
    • Cancer Immunotherapy and Biomarkers 4
    • CAR-T cell therapy research 3

Thomas Tueting

15 papers receiving 302 citations

Peers

Thomas Tueting
Comparison fields: 5 of 64
  • Immunology 118
  • Radiology, Nuclear Medicine and Imaging 60
  • Oncology 68
  • Microbiology 2
  • Pharmacology 42
Replace IG Rennie with:
IG Rennie United Kingdom
David Urech Switzerland
Shixi Liu China
Tomás Blanco United States
Iman Tadmori United States
Sang Goo Lee South Korea
Jörg Wendler Germany
Kazuo Nakatsuka Japan
David G. Yee United States
Yash Mittal United States
Thomas Tueting relative to IG Rennie United Kingdom IG Rennie's profile →
Citations per field
00.5×
IG Rennie · 1×
Citations per year

Countries citing papers authored by Thomas Tueting

Since Specialization
Citations

This map shows the geographic impact of Thomas Tueting's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Tueting with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Tueting more than expected).

Fields of papers citing papers by Thomas Tueting

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Tueting. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Tueting. The network helps show where Thomas Tueting may publish in the future.

Co-authors

The 25 scholars most cited alongside Thomas Tueting, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Thomas Tueting Line = papers co-authored together Thomas Tueting links everyone, so they are left out of the graph.

All Works

15 of 15 papers shown
#Work
1 201363
2 200562
3
The role of interleukin-2, interleukin-12, and dendritic cells in cancer therapy.
199758
4 201052
5 201630
6 200419
7 20196
8 20186
9 20184
10 19973
11 20192
12
Prophylaxis and therapy of ongoing immune responses by IL-10-treated dendritic cells in vivo
19991
13 20041
14 20131
15 19971

About Thomas Tueting

Thomas Tueting is a scholar working on Immunology, Oncology, Epidemiology, Molecular Biology and Cellular and Molecular Neuroscience, having authored 15 papers that have together received 309 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (7 papers), Cancer Immunotherapy and Biomarkers (4 papers), CAR-T cell therapy research (3 papers), T-cell and B-cell Immunology (2 papers), Immune Cell Function and Interaction (2 papers), Nanomaterials and Printing Technologies (1 paper), Microbial Inactivation Methods (1 paper) and Angiogenesis and VEGF in Cancer (1 paper). The work is most often cited by research in Immunology (118 citations), Radiology, Nuclear Medicine and Imaging (60 citations), Oncology (68 citations), Microbiology (2 citations) and Pharmacology (42 citations). Thomas Tueting has collaborated with scholars based in Germany, United States and Australia. Frequent co-authors include Thomas Bieber, Manfred Uerlich, Joerg Wenzel, Otto Haller, Evelyn Gaffal, Sönke Langner, Daniela Mauer, Kerstin Michel, Sebastian Scholz and Christoph A. Ritter. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, British Journal of Dermatology, Experimental Dermatology and Journal of Cutaneous Pathology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact